Flash | 27 Jul 2026 20:05:34 ET │ 10 pages Lexicon Pharmaceuticals (LXRX.O) Enrollment Completion in Ph3 SONATA-HCM Sets Up Potentially Transformative Stock Catalyst in 1Q27 CITI'S TAKE The Ph3 SONATA-HCM trial completed enrollment on schedule, with topline still expected 1Q27. The study substantially exceeded the 500- patient target, boosting statistical power to detect a placebo-adjusted KCCQ-CSS improvement in the 4–5 point range, consistent with the historically accepted clinical meaningfulness threshol ...